Q4 Earnings Preview: Pfizer, Amgen, Allergan, Biogen And Novartis

 
• By Joseph Haas, Jessica Merrill, Eleanor Malone, Mandy Jackson, and Kevin Grogan

Pfizer's fourth-quarter call will be the first with new CEO Albert Bourla, while Amgen will provide reassurances after US Neulasta and Epogen biosimilar launches. Also, concerns swirl around the impending impact of generics on Allergan's blockbuster Restasis, Biogen investors await news on Alzheimer's programs and M&A, and Novartis will face scrutiny of recent launches.

Waiter
What will big pharma dish up in their annual results calls? • Source: Shutterstock

More from Earnings

More from Business